GGrantIndex
← Leaderboards

Jan M Bruder

University Of Texas Hlth Sci Ctr San Ant

$2,532,688
Attributed
$2,532,688
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $127.5K · FY200507
$200K$150K$100K$50K$0
'05
'06
'07

Funding mix

By agency

NIH$2,532,688 · 9

By mechanism

M01$2,532,688 · 9

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Sci Ctr San Ant

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectBone DensityPathologic Bone ResorptionLongitudinal Human StudyOsteoporosisBone FractureMaleProstate NeoplasmsAlendronateHuman Therapy EvaluationWomen'S HealthPatient /Disease RegistryPhysiologic Bone ResorptionOutcomes ResearchPrognosisOsteitis DeformansDisease /Disorder Proneness /RiskMale CastrationOsteoclastsMeasles VirusNeoplasm /Cancer SurgeryInterleukin 6Diphosphonate

Grant awards (20)

GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION$32,417
M01 · FY2007 · RR · contact PI
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION$79,832
M01 · FY2006 · RR · contact PI
PREVENTION OF BONE LOSS WITH ALENDRONATE IN PROSTATE CANCER WITH HORMONE DEPRIVA$446
M01 · FY2006 · RR · contact PI
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION$125,084
M01 · FY2005 · RR
PREVENTION OF BONE LOSS WITH ALENDRONATE IN PROSTATE CANCER WITH HORMONE DEPRIVA$2,397
M01 · FY2005 · RR
Genetics of Bone Density in Mexican Americans$108,066
M01 · FY2004 · RR
Acculturation/Diet/Workload Effect on Bone Density in MA$15,541
M01 · FY2004 · RR
Alendronate Therapy for Bone Loss in Prostate Cancer$6,145
M01 · FY2004 · RR
EFFECT OF ANTIRESORPTIVES IN PATIENTS W/ PAGETS DISEASE$234,837
M01 · FY2002 · RR
DETERMINATION OF RATE OF BONE LOSS IN MEN UNDERGOING CASTRATION FOR CANCER$234,837
M01 · FY2002 · RR
DETERMINATION OF RATE OF BONE LOSS IN MEN UNDERGOING CASTRATION FOR CANCER$234,837
M01 · FY2002 · RR
NATIONAL OSTEOPOROSIS RISK ASSESSMENT$234,837
M01 · FY2002 · RR
NATIONAL OSTEOPOROSIS RISK ASSESSMENT$234,837
M01 · FY2002 · RR
EFFECT OF ANTIRESORPTIVES IN PATIENTS W/ PAGETS DISEASE$234,837
M01 · FY2002 · RR
EFFECT OF ANTIRESORPTIVES IN PATIENTS W/ PAGETS DISEASE$234,837
M01 · FY2001 · RR
NATIONAL OSTEOPOROSIS RISK ASSESSMENT$234,837
M01 · FY2001 · RR
DETERMINATION OF RATE OF BONE LOSS IN MEN UNDERGOING CASTRATION FOR CANCER$234,837
M01 · FY2001 · RR
DETERMINATION OF RATE OF BONE LOSS IN MEN UNDERGOING CASTRATION FOR CANCER$16,409
M01 · FY2000 · RR
EFFECT OF ANTIRESORPTIVES IN PATIENTS W/ PAGETS DISEASE$16,409
M01 · FY2000 · RR
NATIONAL OSTEOPOROSIS RISK ASSESSMENT$16,409
M01 · FY2000 · RR